Amicus Therapeutics Reports Preliminary 2023 Revenue and
2023 Total Revenue of ~$399.4M, a 21% Increase Year-Over-Year >2,400 People Living with Fabry Disease on Galafold® Following a Year of Increased Demand...
Akoya Biosciences Announces Preliminary Financial Results
MARLBOROUGH, Mass., Jan. 07, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced preliminary unaudited...
Hashdex Bitcoin Futures ETF Successfully Transfers to
MILWAUKEE, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Tidal Investments LLC, a leading name in the ETF industry, is pleased to announce the...
Cytokinetics Announces Inducement Grants Under Nasdaq
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on December 29, 2023 it...
Nanophase Announces Rights Offering to Stockholders
ROMEOVILLE, Ill., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-based and scientifically-driven health care solutions...
Societal CDMO Reports Inducement Grants for New Staff
SAN DIEGO and GAINESVILLE, Ga., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASDAQ: SCTL), a contract development and...
Semantix Provides Update Regarding Nasdaq Minimum Bid Price
SÃO PAULO, Brazil, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Semantix, Inc. (NASDAQ: STIX), a leading Latin American enterprise AI platform and applications...
Sparton Announces Revision to Closing of Second Tranche of
Not for distribution to United States Newswire Services or for dissemination in the United States TORONTO, Jan. 05, 2024 (GLOBE NEWSWIRE)...
LumiraDx Announces its Securities will be Suspended from
LONDON, Jan. 05, 2024 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX)(the “Company”) today announced that it has received notification from The Nasdaq...
NurExone Announces Closing of a Private Placement for Gross
TORONTO and HAIFA, Israel , Jan. 05, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (the “Company” or...
Terns Pharmaceuticals Reports Inducement Grant to New
FOSTER CITY, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company...
Voyager Therapeutics Announces Pricing of Public Offering
LEXINGTON, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today...
